OncoTherapy Science Employee Directory

OncoTherapy Science corporate office is located in 1-2 Higashida-cho Kawasaki-ku, Kawasaki-shi, Kanagawa, 213-0012, Japan and has 11-50 employees.

OncoTherapy Science Global Presence

globalPresence illustration
Asia1-10

Key Employees of OncoTherapy Science

  • KT
    Japan flag for contact location.
    Kensuke Tomita

    President

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Index of contact profiles from OncoTherapy Science

Hundreds of professionals searching for OncoTherapy Science have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at OncoTherapy Science

Explore people who held key positions, contributed to OncoTherapy Science's success, and advanced their careers.

People from Similar Companies in the Business Services Industry Located in Japan

Frequently Asked Questions Regarding OncoTherapy Science Employees

How many employees does OncoTherapy Science have?
OncoTherapy Science has 11-50 employees
Who are OncoTherapy Science key employees?
Some of OncoTherapy Science key employees are Kensuke Tomita
Where is OncoTherapy Science located?
OncoTherapy Science’s headquarters are located at 1-2 Higashida-cho Kawasaki-ku, Kawasaki-shi, Kanagawa, 213-0012, Japan
How do I contact OncoTherapy Science?
OncoTherapy Science Contact Info: Phone number: +81 442016429 Website: www.oncotherapy.co.jp
What does OncoTherapy Science do?

OncoTherapy Science, Inc. researches and develops anti-cancer medicines and therapies in Japan. Its clinical development product pipeline includes small-molecule drugs, such as OTS167, a maternal embryonic leucine zipper kinase inhibitor that is in Phase I/II clinical trials for the treatment of acute myeloid leukemia, as well as in Phase I clinica... l trials for the treatment of breast cancer; and OTS964, a T-LAK cell-originated protein kinase inhibitor for the treatment of various cancer diseases. The company's clinical development product pipeline also comprise cancer- specific peptide vaccines, including S-588410, which is in Phase III clinical trials for the treatment esophageal cancer, as well as in Phase II clinical trials for the treatment of bladder cancer; S-488210 that is in Phase I/II clinical trials for the treatment of head and neck cancer; and S-588210, which is in Phase I clinical trials for the treatment of solid tumor. In addition, it is developing antibody drugs consisting of OTSA101, which is in Phase I clinical trials for synovial sarcoma; and KHK6640, an anti-amyloid beta peptide antibody that is Phase I clinical trials for Alzheimer's disease. Further, the company provides contract analysis services. OncoTherapy Science, Inc. was founded in 2001 and is headquartered in Kawasaki, Japan.Read More

Is OncoTherapy Science a public company?
OncoTherapy Science is private company therefore does not currently have an official ticker symbol
See more information about OncoTherapy Science Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.